Stroke, Neurology and Cerebrovascular Diseases

More than 20 years of experience in Medicine and Stroke Medicine. Fellow of the Royal College Of Physicisns. Works in MSE NHS Foundation Trust and expert in provision of Interventional services.

Cryptogenic Stroke

Felipe Padilla Vazquez Specialist in Neurointervention, Neuropathic Endovascular Therapy, Cerebrovascular Diseases, Column Surgery, CNS Oncological Surgery, Headaches, Neuropathic Pain and present time he is Member of the Mexican Society of Neurological Surgery AC.

Stroke, Neurosurgery

Dr. Shen Jiangang is Professor in School of Chinese Medicine, University of Hong Kong. He also serves as Associate Director (Research) and Chair of Department of Research Postgraduate Students Committee in the School. Dr. Shen’s major research interests focus on molecular regulations of oxidative stress and redox signaling in brain damage and brain repair in post-stroke and neurodegenerative diseases. He is also interested in the experimental and clinical studies on Chinese herbal medicine for cerebral and cardiovascular diseases. His studies have been supported by many prestigious research funds from Hong Kong, Mainland China and others. He has published more than 150 peer-reviewed papers in prestigious academic journals and 14 book chapters. He received many academic and research awards and appointed as honor professorship 15 universities from China and USA. He serves as the editorial board members for many international academic journals including Toxicology and Applied Pharmacology, Scientific Reports and others.

Stroke

Dr Javier Cuevas is a Professor of College of Medicine Family Medicine, Professor, Department of Molecular Pharmacology and Physiology, College of Medicine Professor, Pharmaceutical Sciences, College of Pharmacy Assoc Professor, Cop Dept of Pharmaceutical Science Associate Professor, Department of Molecular Pharmacology and Physiology, College of Medicine Member, Department of Molecular Pharmacology and Physiology Executive Committee, College of Medicine Professor, College of Medicine Molecular Pharmacology & Physiology Member, Neuroscience Signature Program Executive Committee, College of Medicine Member, Diversity and Equal Opportunity Office

Exploring overlapping molecular mechanisms involved in expansion of the ischemic core in large-vessel stroke and infarct coalesces in lacunar infarcts

Hans von Holst received his Medical Doctor´s degree in 1976 and specialist in Neurosurgery 1982 at Karolinska University Hospital. In 1985 he earned his PhD and Associate Professorship in Neurosurgery, Clinical Neuroscience at Karolinska Institutet. During 1991-1996 he was appointed as Chairman of the Dept of Neurosurgery and Division Manager of the Neuroclinics at Karolinska University Hospital, respectively. He has been appointed as senior neurosurgeon from 1974 to 2015. Between 1995-2015 he was appointed as Professor in Neuroengineering at the Royal Institute of Technology. He has published around 150 original papers in reputed journals, reviews and books and has been serving as an editorial board member in several journals.

Stroke, TBI, Dementia

Sylvain Doré, PhD is a Professor and Program Director of Research Operations in the Department of Anesthesiology, as well as Professor of Neurology, Psychiatry, Pharmaceutics, and Neuroscience, at the University of Florida, College of Medicine. Dr. Doré attained his PhD, in biomedical science, from the University of Montreal and an MS degree in pharmacology at the University of Quebec. He received post-PhD training in psychiatry at McGill University, as well as post-PhD training in neuroscience at Johns Hopkins University. Dr. Doré’s research pertains to studying new effective mechanisms that limit neuronal dysfunction associated with ischemic and hemorrhagic stroke, Alzheimer disease (AD), aging, and various other neurological disorders. His objective is focused on understanding the protective role of heme metabolites in the brain using cellular/molecular techniques and various models of stroke, Alzheimer disease, and aging. New knowledge is gained specifically, by investigating the action and the role of activity of the heme oxygenase enzyme and its unique bioactive metabolites, namely, carbon monoxide, iron, biliverdin, and bilirubin. His overall goal is to slow down the progression of the disease, and ultimately stop it.

Neurodigenerative disorders, ischemic stroke, Alzheimer’s disease, aging, heme oxygenase, prostaglandins

Professor WK Tang was appointed to professor in the Department of Psychiatry, the Chinese University of Hong Kong in 2011. His main research areas are Addictions and Neuropsychiatry in Stroke. Professor Tang has published over 100 papers in renowned journals, and has also contributed to the peer review of 40 journals. He has secured over 20 major competitive research grants. He has served the editorial boards of five scientific journals. He was also a recipient of the Young Researcher Award in 2007, awarded by the Chinese University of Hong Kong.

Stroke, Psychiatry and Psychology

Neuroscience Research NEUROHEALTH NEUROCIENCIAS Aplicadas (NEURONA) at Neurohealth Neurociencias Aplicadas, Senior management - Founder and researcher Neuroscientist at Fundacion Neurona and rotating internship - applied researcher at UNCIP Unidad de Neurocirugía Pediátrica

Neuroscience, Neurology

Graduated in Medicin from Universidade Federal de Santa Catarina (1988), medical residence in internal medicine and clinical neurology (1989-93); masters in internal medicine by Universidade Federal do Paraná (2003); PhD by Universidade de São Paulo (2008); Post- Doctoral by University of Edinburgh, UK (2011). Has experience in Neurology, Collective Health, focusing on Epidemiology, acting on the following subjects: stroke epidemiology, primary and secondary prevention of atherosclerosis, biobank and stroke units. Professor of Neurology and pos-graduation program at University of Joinville, Brazil. Coordinator of Joinville Stroke

Clinical Neurology, Internal medicine

Neurologist and board certified Neurointensivist, currently pursuing further training in Endovascular Surgical Neuroradiology. My research expertise is in the pathophysiology of subarachnoid hemorrhage and especially in cerebral vasospasm as well as acute ischemic stroke. My goal is to synergize my clinical training and research skills; to gain in depth understanding of subarachnoid hemorrhage and ischemic stroke and to better treat various other devastating neurological diseases. I strive to improve patient outcomes by early identification of novel treatment targets and enable innovations in precision medicine.

Neuroradiology, Neurosurgery

Dr. Suhail Rasool has expertise in evaluation and passion in identifying therapeutic modalities for various Neurodegenerative diseases including Alzheimer’s disease. In the last 6 years Dr. Suhail has published more than 20 papers in peer reviewed and high impact factor journals. I have put forth significant contributions to my field. I have screened various conformation antibodies and I also have studied the effects of various antibodies and antigens for treatment of Alzheimer’s disease. I studied the various transgenic mouse mice models and Alzheimer’s disease human brains by utilizing various conformational antibodies and antigens

Alzheimer’s disease, Neurodegenerative diseases

Research Associate at CHU Sainte-Justine, CEO at Neurotechsr and Postdoctoral Researcher at Montreal Neurological Institute. Studied Sciences neurologiques at Université de Montréal

Neurosceince and Neurology

Professor WK Tang was appointed to professor in the Department of Psychiatry, the Chinese University of Hong Kong in 2011. His main research areas are Addictions and Neuropsychiatry in Stroke. Professor Tang has published over 100 papers in renowned journals, and has also contributed to the peer review of 40 journals. He has secured over 20 major competitive research grants. He has served the editorial boards of five scientific journals. He was also a recipient of the Young Researcher Award in 2007, awarded by the Chinese University of Hong Kong.

Psychiatry, Addictions and Neuropsychiatry , Stroke

Bruno Giometto, MD, is the director of Dept. of Neurology in Padova and was coordinator of the PNS Euronetwork. He has published more than 80 papers in peer-reviewed journals. He is Vice-President of the Italian Neurological Society.

NeuroOncology,Neurology

Nancy Ratner, PhD, is interested in understanding mechanisms of peripheral nerve tumor (neurofibroma) formation in neurofibromatosis type 1 (NF1), a common inherited disorder in which children are predisposed to cancer of the nervous system, to learning problems, bone disorders, and other cancers. She identified EGFR and MEK as potential therapeutic targets in NF1 peripheral nerve tumorigenesis, and has developed cell culture and mouse models of NF1 nerve tumorigenesis. Her laboratory has also used analysis of gene expression to identify critical genes in neurofibroma and their malignant derivatives, MPNST.Dr. Ratner received her bachelor's from Brown University, her doctorate from Indiana University, and was a postdoctoral fellow at Washington University in St. Louis. She was a member of the faculty at the University of Cincinnati from 1987 to 2004.

Molecular Biology, Cancer Biology and Neural Tumors.

Guido Cavaletti, MD, is a certified neurologist since 1990. He is the Head of the Experimental Neurology Unit at the University of Milano-Bicocca and has a long-lasting experience in the preclinical and clinical assessment of CIPN. He has published more than 200 full papers in peer-reviewed journals, he is is consulted by the FDA, NIH and EMA and has been serving as associate editor of the Journal of the Peripheral Nervous System and as editorial board member of Experimental neurology and Current medicinal Chemistry.

Neurology

Dr. Aizenberg is an Associate Professor of Neurosurgery at the University of Nebraska Medical Center. She is Board Certified by the American Board of Neurological Surgery. Dr. Aizenberg has completed fellowship training in Neurosurgical Oncology at The University of Texas M. D. Anderson Cancer Center and has a special interest in primary and metastatic tumors of the brain and spine.

NeuroOncology and Neurosurgery

Associate Professor of Neurosurgery at the University of Nebraska Medical Center. She is Board Certified by the American Board of Ammirati Mario is an expert in Neurological Surgery.He has completed fellowship training in Neurosurgical Oncology at The The Ohio State University and has a special interest in primary and metastatic tumors of the brain and spine.

Primary and metastatic tumors of the brain and spine.

Chairman & CEO at Alzheimers Disease International, London, United Kingdom Studied M.B.B.S at University of Mysore Past: st.marys high school,thalacode Lives in Trichur, Kerala, India

Alzheimers and related diseases